Jun Xu

Guangdong Medical College — China

Medicine · Health Sciences

23h-index6.6kcitations87works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(22), Immune Cell Function and Interaction(16), Immunotherapy and Immune Responses(11), Cytokine Signaling Pathways and Interactions(8), Nanowire Synthesis and Applications(7)

Publications87 total

Revealing Patients’ Continuous Intentions to Augmented Reality-Assisted Healthcare Exercise Systems: A Dual-Stage Analysis of PLS-SEM and fsQCA
International Journal of Human-Computer Interaction·2025
Reduction of radiation dose and contrast medium volume in computed tomography pulmonary angiography: adaptation of dual-energy computed tomography (CT) protocols to the body mass index
Clinical Radiology·2025
Polygenic Risk Score and Lung Adenocarcinoma Risk Among Never-Smokers by EGFR Mutation Status: A Brief Report
Journal of Thoracic Oncology·2024· 2 cited
Phospholipid scramblase 1 acts through the IL-6/JAK/STAT3 pathway to promote the malignant progression of glioma
Archives of Biochemistry and Biophysics·2024· 4 cited
HBV Vaccines: Advances and Development
Vaccines·2023· 52 citedOpen Access
BLIMP1 and NR4A3 transcription factors reciprocally regulate antitumor CAR T cell stemness and exhaustion
Science Translational Medicine·2022· 122 citedOpen Access
Combination of Tumor Mutational Burden and DNA Damage Repair Gene Mutations with Stromal/Immune Scores Improved Prognosis Stratification in Patients with Lung Adenocarcinoma
Journal of Oncology·2022· 2 citedOpen Access
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial
Nature Medicine·2022· 456 citedOpen Access
Glycolysis-Related Gene Signature Can Predict Survival and Immune Status of Hepatocellular Carcinoma
Annals of Surgical Oncology·2022· 10 cited
Comprehensive Analysis Identified Mutation-Gene Signature Impacts the Prognosis Through Immune Function in Hepatocellular Carcinoma
Frontiers in Oncology·2022· 1 citedOpen Access
Whole-Brain Radiotherapy Combined With Anlotinib for Multiple Brain Metastases From Non-small Cell Lung Cancer Without Targetable Driver Mutation: A Single-Arm, Phase II Study
Clinical Medicine Insights Oncology·2022· 11 citedOpen Access
The application of oncolytic viruses in cancer therapy
Biotechnology Letters·2021· 7 cited
BET bromodomain protein inhibition reverses chimeric antigen receptor extinction and reinvigorates exhausted T cells in chronic lymphocytic leukemia
Journal of Clinical Investigation·2021· 88 citedOpen Access
Challenges for Governing Mountains Sustainably: Insights From a Global Survey
Mountain Research and Development·2021· 21 citedOpen Access
Three-Dimensional Ex Vivo Culture for Drug Responses of Patient-Derived Gastric Cancer Tissue
Frontiers in Oncology·2021· 8 citedOpen Access
Author Correction: Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
Nature Medicine·2021· 23 citedOpen Access
Injectable Porous Microchips with Oxygen Reservoirs and an Immune-Niche Enhance the Efficacy of CAR T Cell Therapy in Solid Tumors
ACS Applied Materials & Interfaces·2020· 37 cited
Development of chimeric antigen receptor-modified T cells for the treatment of esophageal cancer
Tumori Journal·2020· 15 cited
Characterization of autologous T cells engineered to express NY-ESO-1 TCR with multiplexed CRISPR/Cas9 editing (NYCE T Cells)
Cytotherapy·2020· 2 cited
Pre-clinical development of multiplex-CRISPR-edited cell and gene therapy products
Cytotherapy·2020
page 1 of 5Next →

Frequent Co-authors

Joseph A. Fraietta(14), Simon F. Lacey(12), J. Joseph Melenhorst(12), Carl H. June(11), Bruce L. Levine(10), Irina Kulikovskaya(8), Regina M. Young(7), Megan M. Davis(7), Elena J. Orlando(6), David E Ambrose(6), Minnal Gupta(6), Frederic D. Bushman(6), Mercy Gohil(5), Wei‐Ting Hwang(5), Donald L. Siegel(5), Julie K. Jadlowsky(5), Christopher L. Nobles(5), Zdeněk Hel(5), Lifeng Tian(4), Hans Bitter(4)